Citation: T. Kino et al., Glucocorticoids suppress human immunodeficiency virus type-1 long terminalrepeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology, J STEROID B, 75(4-5), 2000, pp. 283-290
Authors:
Tanawattanacharoen, S
Falk, RJ
Jennette, JC
Kopp, JB
Citation: S. Tanawattanacharoen et al., Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis, AM J KIDNEY, 35(6), 2000, pp. 1166-1174
Authors:
Judge, R
Plewes, JM
Kumar, V
Koke, SC
Kopp, JB
Citation: R. Judge et al., Changes in energy during treatment of depression: An analysis of fluoxetine in double-blind, placebo-controlled trials, J CL PSYCH, 20(6), 2000, pp. 666-672
Authors:
Fava, M
Rosenbaum, JF
Hoog, SL
Tepner, RG
Kopp, JB
Nilsson, ME
Citation: M. Fava et al., Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression, J AFFECT D, 59(2), 2000, pp. 119-126
Authors:
Vodovotz, Y
Lucia, MS
DeLucca, AM
Mitchell, JB
Kopp, JB
Citation: Y. Vodovotz et al., Reduced hematopoietic function and enhanced radiosensitivity of transforming growth factor-beta 1 transgenic mice, INT J CANC, 90(1), 2000, pp. 13-21
Authors:
Mozes, MM
Bottinger, EP
Jacot, TA
Kopp, JB
Citation: Mm. Mozes et al., Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice, J AM S NEPH, 10(2), 1999, pp. 271-280
Authors:
Kino, T
Gragerov, A
Kopp, JB
Stauber, RH
Pavlakis, GN
Chrousos, GP
Citation: T. Kino et al., The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor, J EXP MED, 189(1), 1999, pp. 51-61